Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Summary of webcast Question - 2009/04/06 - 11:34am

Summary of webcast Question - 2009/04/06 - 11:34am

posted on Apr 06, 2009 07:35AM

PTSC Shareholder Webcast: April 14th, 2009 … 4:30 p.m. EST

Shareholder Questions:

1 MMP: - valid or rejected?

2. Moore vs. TPL: - threat or non-event?

3. Crossflo: - profitable or not profitable in fiscal year 2009?

4. Holocom, Talis, Avot: - next steps?

5. M & A: - Are plans for M & A activities on hold, due to lack of money?

6. Stock Repurchase Plan: - stopped?

7. Avot: - Are we planning on investing more into Avot?

8. Nupower: - Who is licensing their technology? TPL? In-house? Newpower/PTSC combo?

9. TPL Expenses: - Is management confident that expenses billed by TPL Ventures is connected to licensing?

10. Moore/USPTO re-validation - Is Moore still involved and cooperating with the USPTO re-validation process?

11. PTSC monitoring Agora board? - Does PTSC have someone that regularly visits the Agoracom board to get a feel for shareholders’ sentiment and input since shareholders no longer have a representative for this purpose?

Share
New Message
Please login to post a reply